EditorialComparing Fecal Immunochemical Tests: Improved Standardization Is Needed
References (20)
- et al.
Stool screening for colorectal cancer: molecular approaches
Gastroenterology
(2005) - et al.
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Gastroenterology
(2008) The imperative of equal funding for studies that evaluate any of the evidence-based, guideline-recommended colorectal cancer screening tests
Clin Gastroenterol Hepatol
(2009)- et al.
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population
Gastroenterology
(2005) - et al.
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer
Gastroenterology
(2012) - et al.
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable
Gastrointest Endosc
(2007) - et al.
Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study
Clin Gastroenterol Hepatol
(2008) - et al.
The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer
Gastroenterology
(2010) - et al.
A comparison of fecal occult-blood tests for colorectal-cancer screening
N Engl J Med
(1996) - et al.
The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect
Arch Intern Med
(2003)
Cited by (47)
Faecal immunochemical tests for haemoglobin: Analytical challenges and potential solutions
2021, Clinica Chimica ActaCitation Excerpt :The volume of buffer within the collection device is also specific to each device. It has been demonstrated that the faecal sample itself will affect results [24]. Faecal samples are not homogeneous, and any blood shed from colorectal lesions is unlikely to be evenly distributed throughout the passed faeces.
Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model
2017, Journal of Cancer PolicyCitation Excerpt :The present study did not attempt to adjust for differences in the age and sex composition and location of studies used to inform TPR’s so that true differences in TPR performance are likely overestimated since variation in the composition of the population will have been included as uncertainty in the TPR‘s. Studies included used a single test type (OC Sensor®) and it is known that variation exists between tests [28,46–49]. In common with other models of screening cost-effectiveness, the time scale required for consideration is very long so that projected future treatment costs, even after discounting, affect predicted cost-effectiveness.
Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution
2023, World Journal of Gastrointestinal OncologyBiomarkers to Detect Early-Stage Colorectal Cancer
2022, BiomedicinesAssessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin
2021, Annals of Clinical Biochemistry
Conflicts of interest The authors disclose the following:
Callum G. Fraser acts as a consultant for Immunostics Inc, Ocean, NJ, USA, and received travel and accommodation for DDW in Chicago, 2011. Alpha Labs Ltd, Eastleigh, Hants, UK, paid travel and accommodation for the WEO CRCSC meeting in Stockholm, 2011.
The remaining authors disclose no conflicts.